Uitgebreid zoeken

Arnd Kaldowski bekleedt de functie van Chief Executive Officer voor Sonova Holding AG en Chief Executive Officer van Sonova AG (een dochteronderneming van Sonova Holding AG). De heer Kaldowski zit ook in het bestuur van de European Hearing Instrument Manufacturing Association. Daarvoor bekleedde hij de functie van Vice President & Group Executive bij Danaher Corp. President voor Beckman Coulter Diagnostics Ltd. President-Diagnostics Division bij Beckman Coulter, Inc. en Executive Vice President-Sales & Marketing bij Leica Microsystems GmbH (allen dochterondernemingen van Danaher Corp.), Investment Director bij Atila Venture Partners Ltd. (Zwitserse tak), Senior Vice President-Sales & Marketing bij Leica Microsystems GmbH (allen dochterondernemingen van Danaher Corp.). (Zwitserse vestiging), Senior Vice President van Siemens Medical Systems, Inc. en Manager bij Boston Consulting Group Holding AG. Hij behaalde een diploma aan de Technische Universitt Darmstadt en een MBA aan INSEAD.

Arnd Zinnhardt is currently a Director at Software AG (U.K.) Ltd., a Member-Supervisory Board at Dürr AG, a Member-Supervisory Board at Aareon AG, and a Member-Supervisory Board at Grant Thornton AG (Germany) and Warth & Klein Grant Thornton GmbH & Co. KG.
Previously, he was a Director-Supervisory Board at IDS Scheer AG, Chief Financial Officer at Software AG, a Partner at BDO AG Wirtschaftsprüfungsgesellschaft, and a Principal at Ernst & Young LLP (Missouri).
He also served as a Member-Supervisory Board at Landesbank Hessen-Thüringen Girozentrale.
Mr. Zinnhardt received his undergraduate degree from Universität zu Köln.

Arnd Christ is the founder of Cf Port GmbH.
He currently holds the position of Chief Financial Officer at Immatics Biotechnologies GmbH and Immatics NV.
Previously, he served as Finance Director at Avery Dennison Corp., Hoechst AG, and Avery Dennison GmbH.
He also held the role of Chief Financial Officer at MediGene AG, Vivoryon Therapeutics NV, NovImmune SA, Proteros biostructures GmbH, and EleGene AG.
Additionally, he was the Chief Financial Officer at InflaRx NV until 2020.
Mr. Christ has also served as a Member-Supervisory Board at Immunocore Holdings Plc.
He obtained an MBA from Boston University and Wuerzburg Schweinfurt University of Applied Sciences.